Latest Earnings Results: Q3 '26
Estimated EPS
$1.36
Reported EPS
$1.52
Surprise
+11.68%
Estimated Rev
$1.6B
Reported Rev
$1.61B
Surprise
+0.49%
• Reported GAAP EPS of $1.52 up 23.58% YoY • Reported revenue of $1.61B up 8.93% YoY • Encompass Health increased Full-Year 2026 guidance to net operating revenue of $6.45B, Adjusted EBITDA of $1.4B, and adjusted EPS of $6.23 to $6.37.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $1.61 | -- | -- | N/A |
Q3 '26 | $1.36 | $1.52 | 11.68% | BEAT |
Q2 '26 | $1.48 | $1.55 | 4.76% | BEAT |
Q1 '26 | $1.49 | $1.60 | 7.09% | BEAT |
Q4 '25 | $1.30 | $1.46 | 12.14% | BEAT |